CHICAGO--(BUSINESS WIRE)--

U.S. HealthWorks, one of the largest operators of occupational healthcare centers in the United States, today announced it has acquired the three Advanced Occupational Medicine Specialists (AOMS) healthcare centers in the Chicago area.

The centers, the first in Illinois for U.S. HealthWorks, are located in downtown Chicago and two nearby suburbs, Bellwood and Schiller Park. The acquisitions bring the total number of U.S. HealthWorks medical and worksite clinics to 182 nationwide in 17 states.

The downtown Chicago center is located at 614 West Monroe Street. The Bellwood center is at 2615 West Harrison. The Schiller Park center is located at 4200 North Mannheim Road, five miles from Chicagos O'Hare International Airport.

Terms of the transaction, effective January 1, 2013, were not disclosed.

The facilities will continue to offer a wide range of occupational healthcare services, including diagnosis and treatment for injury and illness, preventive services, pre-employment and post-offer exams and screening, and return-to-work rehabilitative care. The centers feature state-of-the-art facilities and also provide sports medicine expertise.

The Bellwood center is open from 7 a.m. until midnight on Monday through Friday. The downtown facility has weekday hours of 7 a.m. to 7 p.m., while the Schiller Park centers weekday hours are 7 a.m. until 10 p.m. All three centers are open Saturday from 8 a.m. to noon.

As a provider of occupational medicine in Chicago for many years, we recognize the innovation and resources U.S. HealthWorks will bring to our patients, said Dr. Raj Khanna, medical director of Advanced Occupational Medicine Specialists. U.S. HealthWorks national network of physicians and health centers are a great match for us. Were excited about becoming an integral part of the U.S. HealthWorks team.

Dr. Khanna and his team have tremendous medical experience and have developed a great reputation in Chicago. We welcome these strong additions to the U.S. HealthWorks family, said Gregory Marotta, senior vice president of national operations for U.S. HealthWorks. The Illinois centers build U.S. HealthWorks presence in the Midwest, joining three centers in Indiana and six each in Ohio and Wisconsin.

About U.S. HealthWorks

See the article here:

U.S. HealthWorks Acquires Advanced Occupational Medicine Specialists’ Three Chicago Centers

Dr David Jones

''Recognition is the first step in legitimisation. There's still other specialists around who say: `Oh, there's no need for that, we look after pain ourselves'.''

Resources for chronic pain - Dr Jones prefers the term persistent - are limited, doctors lack knowledge, and patients often get wrong or contradictory advice.

Awareness of chronic pain had been emerging on the radar of health administrators as the indirect costs of pain were being recognised.

It was a ''long road'' to acceptance by the Medical Council.

''They put us through a fairly tight hoop. There's not been any mateship, I can tell you.

''However, they have a role to protect the public, so they were especially interested that we had adequate processes to ensure maintenance of professional standards for our fellows, an area in which we can all lift our game.''

He hoped recognition was another step on the way to increasing resources for pain medicine.

A key task was educating doctors, both those in practice and those in training.

Pain medicine was given ''one afternoon'' in fifth-year clinical medicine and, for some, a little bit of on-the-job work with anaesthetists.

See more here:

Recognition validates pain medicine

WALTHAM, Mass., Jan. 2, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that the first automated version of the BGM Galectin-3(R) blood test has obtained a CE Mark, an important step in the company's commercial strategy.

The BGM Galectin-3 test will be distributed through bioMerieux's VIDAS(R) immunoassay platform which includes about 27,000 installed instruments worldwide. bioMerieux is one of four diagnostic instrument manufacturers partnering with BG Medicine to commercialize automated versions of the BGM Galectin-3 test, and the first to obtain a CE Mark. bioMerieux is preparing a phased launch of the test in Europe and in certain other territories that recognize the CE Mark.

"The BGM Galectin-3 test has the potential to play a major role in improving the management of heart failure," said Eric Bouvier, President and Chief Executive Officer of BG Medicine. "The launch of the first automated version of our test is a watershed and exciting moment for our company. Through its broad CE-marked installed base, bioMerieux is in a position to drive the adoption of the test in Europe. Offering an automated version of the galectin-3 assay is critical for us to obtain broad-based and rapid global adoption. Partnering with bioMerieux, as well as Abbott, Alere and Siemens provides BG Medicine tremendous international coverage to drive commercial adoption over the next several years."

The CE Mark for bioMerieux's automated version of the BGM Galectin-3 test is the latest in a series of steps designed to further BG Medicine's three-pillared business model for the test, which is focused on rapid commercial adoption driven by sales through automated partners, specialized labs and the targeting of US hospitals with high readmissions rates. Recent developments in this commercial strategy have included:

"2013 is poised to be a year of great progress in our commercial strategy for the manual and automated versions of the BGM Galectin-3 test and we are pleased to begin the year with this important development in the execution of this strategy," continued Mr. Bouvier.

About Galectin-3 and Heart Failure

Galectin-3 is a unique carbohydrate-binding lectin, or protein, that binds to carbohydrates called beta-galactosides. Galectin-3 has been implicated in a variety of biological processes important in the development and progression of heart failure, and is believed to be a primary mediator of progressive cardiac fibrosis (abnormal thickening and stiffening of the heart muscle) and adverse remodeling (changes in the structure of the heart). Higher levels of galectin-3 are associated with a more aggressive form of heart failure and 30% or more of mild to moderate heart failure patients will have elevated levels of galectin-3. Heart failure affects an estimated 5.8 million Americans, with approximately 670,000 new cases occurring each year. The direct and indirect cost of heart failure in the United States for 2010 is estimated to be $39.2 billion.

About BG Medicine, Inc.

BG Medicine, Inc. (BGMD) is a diagnostics company focused on the development and commercialization of novel cardiovascular tests to address significant unmet medical needs, improve patient outcomes and reduce healthcare costs. The Company has two products: the BGM Galectin-3(R) test for use in patients with chronic heart failure is available in the United States and Europe; and the CardioSCORE(TM) test for the risk prediction of major cardiovascular events will be launched in Europe in the first half of 2013. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit http://www.bg-medicine.com and http://www.galectin-3.com.

The BG Medicine Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10352

Follow this link:

BG Medicine Announces Obtaining CE Mark and Launching of Automated BGM Galectin-3 Test

CAMBRIDGE, Mass.--(BUSINESS WIRE)--

Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genomic analysis to routine clinical care, today announced that Michael J. Pellini, M.D., president and chief executive officer, will present an overview of the company at the 31st Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Wednesday, January 9, 2013 at 7:30 a.m. PT.

Dr. Pellini will provide an update on the recent commercial launch of Foundation Medicines first clinical product, FoundationOne, a pan-cancer, fully informative genomic profile designed to help oncologists expand their patients treatment options.

About FoundationOneTM

FoundationOne is a fully informative genomic profile that complements traditional cancer decision tools and often expands treatment options by matching each patient with targeted therapies that may be relevant to the molecular changes in their tumor. Using next-generation sequencing, FoundationOne interrogates all genes somatically altered in human cancers that are validated targets for therapy or unambiguous drivers of oncogenesis based on current knowledge. It reveals all classes of genomic alterations including base substitutions, insertions, deletions, copy number alterations and select rearrangements. Each patients genomic profile is reported to the physician matched with targeted therapies and clinical trials that may be relevant based on the molecular blueprint of their tumor. Results are supported by the latest scientific and medical evidence. FoundationOne has been optimized to fit easily into the clinical workflow of a practicing oncologist. It is available for all solid tumors and clinical grade results can be obtained from as little as 50ng of DNA obtained from formalin-fixed, paraffin-embedded tumor tissue samples. FoundationOne is a laboratory-developed test performed at Foundation Medicines CLIA-certified facility and is currently available for all solid tumor types. Please visit http://www.foundationone.com for more information.

About Foundation Medicine

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patients unique cancer. The companys initial clinical assay, FoundationOneTM, is a fully informative genomic profile to identify a patients individual molecular alterations and match them with relevant targeted therapies and clinical trials. Foundation Medicines molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit http://www.foundationmedicine.com.

Foundation Medicine is a registered trademark, and FoundationOneTM is a trademark of Foundation Medicine, Inc.

Follow this link:

Foundation Medicine to Present at the 31st Annual J.P. Morgan Healthcare Conference

By Chelsea Conaboy, Globe Staff

The patient in intensive care had kidney, liver, and lung failure, plus a rash. Nine specialty groups were called in to consult. During 11 days on the unit, at least 40 doctors were part of the mans care. But none pinned down a diagnosis.

In a perspective piece in the New England Journal of Medicine this week, two Yale doctors involved in the mans care cited the case as an example of the bystander effect in medicine. Just as strangers who witness a crime may do nothing, willing to dismiss the incident as someone elses problem, doctors without ownership in a patients care may not act, write Drs. Robert Stavert and Jason Lott, residents in dermatology at Yale School of Medicine. They write:

The case wasnt unique, they said in an interview. They had seen such an effect before, they said, and friends and colleagues they spoke with said they had experienced similar things at other institutions. Increased specialization among doctors plus new rules limiting how many hours residents can work have led to a greater number of doctors being involved in a single patients care, they said, but there has not been of a response to ensure that doctors know each other and have the skills to work as a team.

Getting everyone together can be challenging if theres not systems in place that can make that happen, Stavert said.

Some medical schools have begun investing time in team-building and communications. Brown Universitys Alpert Medical School last year introduced a transitional program for students between their second and third years, before they begin working on hospital wards.

The students spend time getting to know the culture of certain specialties, including surgery and pediatrics, and go through training on how to communicate with specialists about patient needs and to ensure proper follow-up.

Dr. Paul George, a family physician and a course leader for the clerkship, said its a start, but more such training is needed. He echoed a theme the Yale physicians wrote about: The growth of accountable care organizations, in which doctors are rewarded for collaborating with each other to keep their patients healthy, could help.

Im now getting more notes from specialists than ever before, George said.

Hospital programs aimed at helping doctors get to know one another, such as interdisciplinary grand rounds, also could improve communication, the authors said.

Read the original post:

Yale doctors: ‘Bystander effect’ in medicine hinders patient care

Newswise Douglas R. Dirschl, MD, a nationally recognized orthopedic surgeon, administrator, teacher and researcher, will chair the newly created Department of Orthopedic Surgery at the University of Chicago Medicine starting Jan. 1, 2013.

Dirschl is coming to Chicago from the University of North Carolina School of Medicine, where he has been chairman and the Frank C. Wilson Distinguished Professor in the Department of Orthopedics since 2003. He is a former president of the American Orthopaedic Association (AOA), considered the premiere orthopedic academic organization in the United States.

An extensive national search identified Douglas Dirschl as a leader in orthopedic surgery who is held in highest regard nationally and internationally, said Kenneth Polonsky, MD, executive vice president for medical affairs at the University of Chicago and dean of the Biological Sciences Division and Pritzker School of Medicine. He also is known for his clinical and teaching skills, his ability to motivate scientists and clinicians to work toward shared goals, and for elevating standards and practices of patient care and education.

Dirschl has conducted original research relevant to the practice of orthopedic surgery and to the understanding of the biological basis of the surgery. In his studies of the practice, he has focused on the critical assessment of factors that influence reliability in classifying fractures of various types. His studies focus on the quality of radiographs and the reliability of interpretation, as well as the use of binary decision-making strategies to enhance reliability. In his studies of the biological basis of surgery, Dirschl has focused on a variety of biological correlates of orthopedic injury such as hemorrhage in pelvic fractures as a means of classifying factors that influence pelvic bleeding.

As president of the AOA, Dirschl played an instrumental role in the development and launch of the organizations Own the Bone campaign, designed to increase awareness of the serious consequences of bone loss and the growing prevalence of osteoporosis. There are three times as many fragility fractures each year in the United States as there are heart attacks, he said. This is a huge and under-recognized public health issue.

Dirschl described his new role at the University of Chicago Medicine as a remarkable opportunity to expand on current strengths and establish new programs, particularly with the opening of the Center for Care and Discovery.

The medical center already has many outstanding, cohesive, team-oriented faculty, he said. The state-of-the-art surgical facilities in the Center for Care and Discovery will provide unprecedented opportunities for us to expand orthopedics. We intend to double the number of faculty physicians and find innovative ways to deliver superior patient care.

A leader in medical education and health policy, Dirschl has received multiple teaching awards for his work with medical students and residents. He has co-authored three books, 40 book chapters, and more than 75 peer-reviewed scholarly articles and lectured all over the world. He sits on editorial and review boards for several notable scientific journals, including the Journal of Orthopaedic Research, Journal of Orthopaedic Trauma and Operative Techniques in Orthopaedics.

Dirschl graduated with distinction in 1984 from Stanford University with a degree in chemical engineering and with high honors in 1988 from the Oregon Health & Science University (OHSU) School of Medicine. He did his internship in general surgery and residency in orthopedic surgery at the University of North Carolina (UNC) Hospitals, where he joined the faculty in 1993. He returned to OHSU in 2001 as professor and chairman of orthopedics, and was recruited back to UNC in 2003.

He is relocating to Chicago with his spouse, Katie Koenig, an accomplished health care administrator, who will be associate vice president of strategic projects at the University of Chicago Medicine.

Read more:

Douglas Dirschl to Lead Orthopedics at the University of Chicago Medicine

Nobel medicine laureate Rita Levi-Montalcini, a neurologist and developmental biologist, died on Sunday at her home in Rome aged 103.

She was the oldest living Nobel laureate at the time of her death.

Levi-Montalcini shared the prize with colleague Stanley Cohen in 1986 for their ground-breaking discovery of growth factors.

The Nobel committee cited the pair for advancing "our knowledge from a stage when... growth factors were unknown, to a situation today when the role of growth factors in cell proliferation, organ differentiation, and tumour transformation is generally recognised."

Their work has helped understanding of such disorders as cancer, birth defects and Alzheimer's and Parkinson's diseases.

Enjoying great affection and respect in Italy, Levi-Montalcini intervened to defend the teaching of evolution in schools when, in 2004, the then education minister, Letizia Moratti, wanted to remove it from the curriculum.

Born into a wealthy Jewish intellectual family in northern Turin in 1909, Levi-Montalcini was the daughter of an engineer and an artist.

In 2001, Italy's then president Carlo Azeglio Ciampi named Levi-Montalcini a senator for life, an honour bestowed on former presidents and prominent figures in social, scientific, artistic or literary fields.

In this role, she was the grand old lady of the Senate, taking pains to turn up for crucial votes in support of the Italian centre-left, even late in life when she was deaf and nearly blind.

In 2007 she cut short a trip to Dubai to help then prime minister Romano Prodi survive a confidence vote.

Excerpt from:

Nobel medicine laureate Levi-Montalcini dies aged 103

A large population in India still believes that getting bitten by a dog leads to the birth of puppies inside human body. Medical experts say witch doctors are at the root of the bizarre myth.

When 18-year-old Shankari Mahato was bit by a dog in her village in West Midnapur district in the state of West Bengal last month, instead of going to a regular doctor, she went to a witch doctor in a neighbouring village.

The 70-year-old witch doctor Buddheswar Singh had the girl swallow some mysterious herbs mixed with yogurt and flattened rice, and assured her that she would not face any health complications due to the dog bite.

The 18-year-old girl said she went to the witch doctor because she knew his medicine would save her life.

"We know that if people are bit by dogs, puppies will be born inside their stomach. That leads to rabies and eventually death," she told DW. "The medicine the witch doctor gave me cured me completely."

Malati Mahato, Shankari's illiterate mother, said that she too had taken Mr. Singh's medicine after getting bitten by a dog 8 years ago and she was cured.

"In our village whenever someone gets bitten by a dog, the person is usually taken to Mr. Singh for treatment. We don't go to hospital or regular doctors. His medicine is life-saving," Malati told DW.

Superstition

The belief in the so-called "puppy pregnancy syndrome" (PPS) is prevalent among tens of thousands of people in West Bengal, Assam, Bihar, Jharkhand, Orissa, Chhattisgarh and some other Indian states.

Psychiatrist Kumar Kanti Ghosh, who has researched PPS for almost two decades and helped document the phenomenon for an article in the medical journal Lancet in 2003, said a mass hysteria or group delusion was behind the superstitious belief of puppy pregnancy among illiterate or near-illiterate people.

View post:

Medicine challenges Indian superstition

TAKE out your crystal ball for a peek in the future of modern medicine, and the picture that emerges is bright.

Science fiction is becoming fact as modern medicine embraces hi-tech advances, along with surgical, procedural and pharmaceutical developments that boost the power to save lives, and fight off a host of serious illnesses.

Its also true, though, that this "hymn of praise" is not the full picture. Medicine is increasingly being undermined by negative steps and doubts, a function in part of the relationship between doctors and drug companies that grows ever cosier, and which is proving to have an insidious effect on treatment guidelines.

Dr Eric Campbell is an associate professor at Harvard Medical School who has researched conflicts of interest in treatment guidelines, and is quoted as saying: "At the end of the day, the drug companies own medicine. Weve created a system that allows this."

That gives new meaning to the words of the late Austrian polymath, priest, polemicist and "jet-age ascetic", Ivan Illich.

Illich, who died of cancer in 2002, worked in 10 languages and is widely acknowledged as one of the worlds great thinkers on education and medicine.

He once declared that the medical establishment "has become a major threat to health", and that the "disabling impact of professional control over medicine has reached the proportions of epidemic".

Still, the reality is many diseases once deemed untreatable now have a close to 100% recovery rate, and medical scientific breakthroughs continue to change lives and life spans for the better.

In my view, the most positive sign of a healthy future for modern medicine is the rise of what is known as "functional medicine".

South African-born Dr Frank Lipman, who now lives and practises in the US, is already firmly on board. On his website (www.drfranklipman.com) he describes functional medicine as "a true combination of Chinese medicine, western medicine and scientific research".

Read more from the original source:

Peek into the natural future of functional medicine

The Canadian Press Published Saturday, Dec. 29, 2012 3:17PM EST Last Updated Saturday, Dec. 29, 2012 3:30PM EST

MEDICINE HAT, Alta. -- An 18-year-old man from southern Alberta has been charged with making an online threat that allegedly touched on this month's deadly elementary school shooting in Connecticut.

Police in Medicine Hat say they started an investigation on Boxing Day into comments posted on Facebook.

Investigators say the post included remarks about the deadly shooting in Newtown, Conn., and a threat aimed at a Medicine Hat school.

Police did not go into detail in a news release issued Friday evening, but did call the post "disturbing."

The 18-year-old was arrested and has been charged with making threats and publishing obscene matter.

He is being held in custody until his next court appearance Monday.

Police have not named the man charged or the school involved. They also didn't say whether he was a student at the school.

It's the second time in the space of a little more than a week that a young person has been charged with making threats aimed at an Alberta school.

On Dec. 21, a 17-year-old student at Ponoka Composite High School, south of Edmonton, was charged with making threats.

Read more here:

Alberta teen charged with threatening Medicine Hat school

The games have been set.

The rest is here:

Kingman Eagle Classic: Crusaders face Medicine Lodge next week

Personalized medicine is still in its infancy and is expected to drive new levels of partnership activity across the life sciences spectrum, such as: molecular profiling, outcomes data mining, healthcare IT, and data integration.

See the article here:

Defining A Partnership Strategy For Personalized Medicine

MEDICINE PARK, Okla_When most think of winter, going fishing probably isn't the first activity that comes to mind, but the Oklahoma Department of Wildlife is trying to change that. Starting January 1st,

View original post here:

New Trout Fishery Coming To Medicine Park

Big Pharma Tapping Into Traditional Medicine

Read the original here:

Big Pharma Tapping Into Traditional Medicine

Hall of Meat: Best of 2012
Hall of Meat is a harsh reminder of skating #39;s brutality. It #39;s a medicine usually given in small doses... So prepare to overdose. This clip is not for the faint of heart.From:ThrasherMagazineViews:1574 660ratingsTime:04:57More inSports

See original here:

Hall of Meat: Best of 2012 - Video

Black Ops 2 - Ballad of the Christmas Noob (Deep Emotional Video Nominated for 7 Oscars)
I took hardcore cold medicine and shit got weird. Don #39;t fuck with Childrens Nyquil. Follow me on Twitter! twitter.com Like me on Facebook! http://www.facebook.com CLICK LINK BELOW and use promo code #39;Epic #39; for 10% off Custom Controllerzz tinyurl.com CLICK HERE for 10% off Kontrol Freeks! tinyurl.com KYR SP33DY: http://www.youtube.com JahovasWitniss: http://www.youtube.com The Deluxe 4: http://www.youtube.com ShadowBeatzInc: http://www.youtube.com Deluxe 20: http://www.youtube.com SideArms4Reason: http://www.youtube.com G18: http://www.youtube.com Custom Controllerzz: http://www.youtube.com black ops 2 funny black ops 2 funny moments black ops 2 trolling black ops 2 comedy funny black ops 2From:NobodyEpicViews:303 2164ratingsTime:01:49More inGaming

Excerpt from:

Black Ops 2 - Ballad of the Christmas Noob (Deep Emotional Video Nominated for 7 Oscars) - Video

Let #39;s Suck at Project Zomboid! Part 3-- Nature #39;s Cough Medicine
Going up the down stairs. Like it? Tell your friends! Contact: incognito.christ@gmail.comFrom:MrUndercoverJesusViews:0 0ratingsTime:10:27More inGaming

Continue reading here:

Let's Suck at Project Zomboid! Part 3-- Nature's Cough Medicine - Video

eyenine - american double standard
stuck in the middle of another awful riddle how much money can you make after only spending a little? this is the sum of the business of american standards for living i #39;m sick of the system and of all that it stands for, i #39;ve given too much of myself to be divided by peers like they #39;ve been dying to hear why i #39;m not blinded by fear well my eyes have been clear, since the day that i could open them i #39;ve never trusted anything i couldn #39;t see the focus of [we trust the local doctors, we trust the medicine] but we never even bother to look beyond all the dollars that they spend on hiding side effects from all the pills they tend to give this entire nation can pretend to be complacent when it #39;s spending hard earned money getting all these vaccinations well i #39;m saving all my earnings and my desire for learning #39;til i #39;m certain that a hospital #39;s only purpose is curing THIS IS AMERICAN. DOUBLE STANDARD. This is something that we face every single day, we can #39;t look away, we can #39;t look away. we #39;ve all been sitting right in front of televisions for the past 80 years, we #39;ve let it make our decisions it tells us where to eat, what to buy and when to sleep when to laugh, when to cry and when to accept defeat they #39;re pushing their product all on the targeted market audience selling them all the obvious objects that always promise us lies but we never even see it as criminal it #39;s disgusting but i blame it on our weakness to subliminal advertising bastardizing all of our decency ...From:eyenineViews:7 0ratingsTime:03:01More inMusic

Read the rest here:

eyenine - american double standard - Video

Welcome to Hillside Animal Hospital - Scottsdale, AZ
hillsidepets.com - Call us today at (480) 391-7297. At Hillside Animal Hospital, we are committed to providing the best quality patient care available. We are a full service animal hospital and specialize in General Veterinary Care, Surgical, and Stem Cell Medicine. In addition our facility is equipped with Ultrasound, Digital X-Ray, Endoscopy, and Laprascopic Equipment. Our office is located in Scottsdale, AZ and serves the surrounding communities of Paradise Valley and Fountain Hills.From:HillsideAHViews:0 0ratingsTime:01:35More inPets Animals

Excerpt from:

Welcome to Hillside Animal Hospital - Scottsdale, AZ - Video

Hillside Animal Hospital - Short | Scottsdale, AZ
hillsidepets.com - Call us today at (480) 391-7297. At Hillside Animal Hospital, we specialize in Surgical, General Veterinary Care, and Stem Cell Medicine. In addition our facility is equipped with Endoscopy, Digital X-Ray, Ultrasound, and Laprascopic Equipment. We are located in Scottsdale, AZ and serve the surrounding communities of Paradise Valley and Fountain Hills.From:HillsideAHViews:0 0ratingsTime:00:16More inPets Animals

Read more here:

Hillside Animal Hospital - Short | Scottsdale, AZ - Video